ISIN | AT0000A0XMM2 |
---|---|
Valor Number | 19994591 |
Bloomberg Global ID | |
Fund Name | DSC Equity Fund – Healthcare A |
Fund Provider |
Dreyfus Söhne & Cie AG, Banquiers
Aeschenvorstadt 16 | Postfach 4051 Basel Schweiz Phone: +41 61 286 66 66 Web: https://www.dreyfusbank.ch |
Fund Provider | Dreyfus Söhne & Cie AG, Banquiers |
Representative in Switzerland |
Dreyfus Söhne & Cie AG, Banquiers Basel |
Distributor(s) |
Dreyfus Söhne & Cie AG, Banquiers Basel |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Austria |
Issuing Condition | The fund does not charge any issuing commission and/or fees (units are issued at the NAV) |
Redemption Condition | The fund does not charge any redemption commission and/or fees (units are redeemed at the NAV) |
Investment Strategy *** | N/A |
Peculiarities |
Current Price * | 194.83 CHF | 11.04.2025 |
---|---|---|
Previous Price * | 198.94 CHF | 10.04.2025 |
52 Week High * | 239.85 CHF | 03.09.2024 |
52 Week Low * | 194.83 CHF | 11.04.2025 |
NAV * | 194.83 CHF | 11.04.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 41,387,253 | |
Unit/Share Assets *** | 1,365,976 | |
Trading Information SIX |
YTD Performance | -10.47% |
30.12.2024 - 11.04.2025
30.12.2024 11.04.2025 |
---|---|---|
1 month | -13.89% |
11.03.2025 - 11.04.2025
11.03.2025 11.04.2025 |
3 months | -12.88% |
14.01.2025 - 11.04.2025
14.01.2025 11.04.2025 |
6 months | -15.96% |
11.10.2024 - 11.04.2025
11.10.2024 11.04.2025 |
1 year | -14.96% |
11.04.2024 - 11.04.2025
11.04.2024 11.04.2025 |
2 years | -11.55% |
11.04.2023 - 11.04.2025
11.04.2023 11.04.2025 |
3 years | -22.59% |
11.04.2022 - 11.04.2025
11.04.2022 11.04.2025 |
5 years | -3.37% |
14.04.2020 - 11.04.2025
14.04.2020 11.04.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Eli Lilly and Co | 7.98% | |
---|---|---|
Johnson & Johnson | 7.01% | |
UnitedHealth Group Inc | 5.78% | |
Abbott Laboratories | 5.05% | |
AbbVie Inc | 4.51% | |
Merck & Co Inc | 4.08% | |
AstraZeneca PLC | 3.52% | |
Sanofi SA | 3.42% | |
Intuitive Surgical Inc | 3.27% | |
Novo Nordisk AS Class B | 3.22% | |
Last data update | 28.02.2025 |
TER | 1.53% |
---|---|
TER date | 30.04.2024 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.50% |
Ongoing Charges *** | 1.52% |
SRRI ***
|
|
SRRI date *** | 31.03.2025 |